At last, direct evidence that lipoxygenases play a role in atherogenesis
Open Access
- 1 June 1999
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 103 (11) , 1487-1488
- https://doi.org/10.1172/jci7298
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E–deficient miceJournal of Clinical Investigation, 1999
- Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient miceNature Medicine, 1998
- Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice.Journal of Clinical Investigation, 1997
- The role of 15-lipoxygenase in atherogenesis: pro- and antiatherogenic actionsCurrent Opinion in Lipidology, 1997
- Attenuation of diet‐induced atherosclerosis in rabbits with a highly selective 15‐lipoxygenase inhibitor lacking significant antioxidant propertiesBritish Journal of Pharmacology, 1997
- Lewis A. Conner Memorial LectureCirculation, 1997
- Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development.Journal of Clinical Investigation, 1996
- Effect of the Antioxidant N,N′ -Diphenyl 1,4-Phenylenediamine (DPPD) on Atherosclerosis in ApoE-Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Beyond CholesterolNew England Journal of Medicine, 1989
- Book ReviewAmbulatory Pediatric CareNew England Journal of Medicine, 1989